309 related articles for article (PubMed ID: 24141377)
1. Isolated hepatic perfusion for ocular melanoma metastasis: registry data suggests a survival benefit.
Olofsson R; Cahlin C; All-Ericsson C; Hashimi F; Mattsson J; Rizell M; Lindnér P
Ann Surg Oncol; 2014 Feb; 21(2):466-72. PubMed ID: 24141377
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver.
Alexander HR; Libutti SK; Pingpank JF; Steinberg SM; Bartlett DL; Helsabeck C; Beresneva T
Clin Cancer Res; 2003 Dec; 9(17):6343-9. PubMed ID: 14695133
[TBL] [Abstract][Full Text] [Related]
3. Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial.
Olofsson R; Ny L; Eilard MS; Rizell M; Cahlin C; Stierner U; Lönn U; Hansson J; Ljuslinder I; Lundgren L; Ullenhag G; Kiilgaard JF; Nilsson J; Lindnér P
Trials; 2014 Aug; 15():317. PubMed ID: 25106493
[TBL] [Abstract][Full Text] [Related]
4. Isolated hepatic perfusion with high-dose melphalan results in immediate alterations in tumor gene expression in patients with metastatic ocular melanoma.
Varghese S; Xu H; Bartlett D; Hughes M; Pingpank JF; Beresnev T; Alexander HR
Ann Surg Oncol; 2010 Jul; 17(7):1870-7. PubMed ID: 20221901
[TBL] [Abstract][Full Text] [Related]
5. Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases.
van Etten B; de Wilt JH; Brunstein F; Eggermont AM; Verhoef C
Eur J Surg Oncol; 2009 May; 35(5):539-45. PubMed ID: 18760560
[TBL] [Abstract][Full Text] [Related]
6. Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver.
Noter SL; Rothbarth J; Pijl ME; Keunen JE; Hartgrink HH; Tijl FG; Kuppen PJ; van de Velde CJ; Tollenaar RA
Melanoma Res; 2004 Feb; 14(1):67-72. PubMed ID: 15091197
[TBL] [Abstract][Full Text] [Related]
7. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.
Alexander HR; Libutti SK; Bartlett DL; Puhlmann M; Fraker DL; Bachenheimer LC
Clin Cancer Res; 2000 Aug; 6(8):3062-70. PubMed ID: 10955785
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic Perfusion.
Ben-Shabat I; Belgrano V; Ny L; Nilsson J; Lindnér P; Olofsson Bagge R
Ann Surg Oncol; 2016 Apr; 23(4):1327-34. PubMed ID: 26628434
[TBL] [Abstract][Full Text] [Related]
9. Isolated hepatic perfusion for liver metastases of malignant melanoma.
Rizell M; Mattson J; Cahlin C; Hafström L; Lindner P; Olausson M
Melanoma Res; 2008 Apr; 18(2):120-6. PubMed ID: 18337648
[TBL] [Abstract][Full Text] [Related]
10. Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy.
Alexander HR; Libutti SK; Pingpank JF; Bartlett DL; Helsabeck C; Beresneva T
Ann Surg Oncol; 2005 Feb; 12(2):138-44. PubMed ID: 15827794
[TBL] [Abstract][Full Text] [Related]
11. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer.
Bartlett DL; Libutti SK; Figg WD; Fraker DL; Alexander HR
Surgery; 2001 Feb; 129(2):176-87. PubMed ID: 11174711
[TBL] [Abstract][Full Text] [Related]
12. Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial).
Olofsson Bagge R; Nelson A; Shafazand A; All-Eriksson C; Cahlin C; Elander N; Helgadottir H; Kiilgaard JF; Kinhult S; Ljuslinder I; Mattsson J; Rizell M; Sternby Eilard M; Ullenhag GJ; Nilsson JA; Ny L; Lindnér P
J Clin Oncol; 2023 Jun; 41(16):3042-3050. PubMed ID: 36940407
[TBL] [Abstract][Full Text] [Related]
13. Treatment of melanoma metastases confined to the liver and future perspectives.
Vahrmeijer AL; van de Velde CJ; Hartgrink HH; Tollenaar RA
Dig Surg; 2008; 25(6):467-72. PubMed ID: 19212119
[TBL] [Abstract][Full Text] [Related]
14. Outcome analysis of a decade-long experience of isolated hepatic perfusion for unresectable liver metastases at a single institution.
Magge D; Choudry HA; Zeh HJ; Cunningham DE; Steel J; Holtzman MP; Jones HL; Pingpank JF; Bartlett DL; Zureikat AH
Ann Surg; 2014 May; 259(5):953-9. PubMed ID: 24169176
[TBL] [Abstract][Full Text] [Related]
15. Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma.
Boone BA; Perkins S; Bandi R; Santos E; McCluskey K; Bartlett DL; Pingpank JF
J Surg Oncol; 2018 Apr; 117(5):940-946. PubMed ID: 29878390
[TBL] [Abstract][Full Text] [Related]
16. The past decade of experience with isolated hepatic perfusion.
Grover A; Alexander HR
Oncologist; 2004; 9(6):653-64. PubMed ID: 15561809
[TBL] [Abstract][Full Text] [Related]
17. Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan.
Lindnér P; Fjälling M; Hafström L; Kierulff-Nielsen H; Mattsson J; Scherstén T; Rizell M; Naredi P
Eur J Surg Oncol; 1999 Apr; 25(2):179-85. PubMed ID: 10218462
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous Isolated Hepatic Perfusion as a Treatment for Isolated Hepatic Metastases of Uveal Melanoma: Patient Outcome and Safety in a Multi-centre Study.
Vogl TJ; Koch SA; Lotz G; Gebauer B; Willinek W; Engelke C; Brüning R; Zeile M; Wacker F; Vogel A; Radeleff B; Scholtz JE
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):864-872. PubMed ID: 28144756
[TBL] [Abstract][Full Text] [Related]
19. Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases; a new simplified technique in isolated hepatic perfusion.
Verhoef C; de Wilt JH; Brunstein F; Marinelli AW; van Etten B; Vermaas M; Guetens G; de Boeck G; de Bruijn EA; Eggermont AM
Ann Surg Oncol; 2008 May; 15(5):1367-74. PubMed ID: 18239976
[TBL] [Abstract][Full Text] [Related]
20. Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver.
Rothbarth J; Pijl ME; Vahrmeijer AL; Hartgrink HH; Tijl FG; Kuppen PJ; Tollenaar RA; van de Velde CJ
Br J Surg; 2003 Nov; 90(11):1391-7. PubMed ID: 14598420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
